Y-Intercept (HK)’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-345,571
Closed -$1.83M 2211
2026
Q1
$1.83M Sell
345,571
-18,712
-5% -$115K 0.03% 756
2025
Q4
$2.81M Buy
364,283
+349,985
+2,448% +$3.12M 0.06% 453
2025
Q3
$126K Sell
14,298
-140,619
-91% -$1.05M ﹤0.01% 1483
2025
Q2
$643K Buy
+154,917
New +$970K 0.02% 1109
2024
Q2
Sell
-19,394
Closed -$229K 1967
2024
Q1
$229K Buy
+19,394
New +$224K 0.02% 1085
2022
Q3
Sell
-2,136
Closed -$30K 1298
2022
Q2
$30K Buy
+2,136
New +$34K ﹤0.01% 776

Other funds holding VSTM

Y-Intercept (HK)'s VSTM Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Verastem (VSTM) in Q2 2026, closing a stake of 345,571 shares — an estimated $1.83M sold.

Y-Intercept (HK) first reported a position in VSTM in Q2 2022 and held it in 6 quarters. The position peaked at $2.81M in Q4 2025. 17 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Verastem position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 345,571 Verastem shares in Q2 2026, an estimated $1.83M.
  • Y-Intercept (HK) first reported a position in Verastem in Q2 2022 and held it in 6 quarters.
  • Y-Intercept (HK)'s Verastem position peaked at $2.81M in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.